Liminatus Pharma
$2.82
17
-$0.07-2.59%Friday 20:00
+$0.01+0.35%Friday 23:49After hours
Statistics
Day High
2.75
Day Low
2.75
52W High
102.5
52W Low
2.82
Volume
483
Avg. Volume
-
Mkt Cap
3.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-10.21MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LIMN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
Show More
CEO
Chris Kim
Employees
1
Country
United States
ISIN
US53271X2071
Listings
0 Comments
Share your thoughts
FAQs
What is Liminatus Pharma stock price today?▼
The current price of LIMN is $2.82 USD — it has decreased by -2.59% in the past 24 hours. Watch Liminatus Pharma stock price performance more closely on the chart.
What is Liminatus Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Liminatus Pharma stocks are traded under the ticker LIMN.
Is Liminatus Pharma stock price growing?▼
LIMN stock has fallen by -10.76% compared to the previous week, the month change is a -27.69% fall, over the last year Liminatus Pharma has showed a -95.94% decrease.
What is Liminatus Pharma market cap?▼
Today Liminatus Pharma has the market capitalization of 3.79M
What is Liminatus Pharma revenue for the last year?▼
Liminatus Pharma revenue for the last year amounts to 0 USD.
What is Liminatus Pharma net income for the last year?▼
LIMN net income for the last year is -10.21M USD.
How many employees does Liminatus Pharma have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Liminatus Pharma located?▼
Liminatus Pharma operates in the Health & Wellness sector.
When did Liminatus Pharma complete a stock split?▼
The last stock split for Liminatus Pharma was on August 21, 2026 with a ratio of 1:50.
Where is Liminatus Pharma headquartered?▼
Liminatus Pharma is headquartered in CERRITOS, United States.